Departments of Surgery, Kyungpook National University Medical Centre, Kyungpook National University School of Medicine, Daegu, Korea.
Yonsei University College of Medicine, Seoul, Korea.
Br J Surg. 2015 Nov;102(12):1567-73. doi: 10.1002/bjs.9914. Epub 2015 Aug 27.
There is a lack of information regarding the oncological safety of robotic intersphincteric resection (ISR) with coloanal anastomosis. The objective of this study was to compare the long-term feasibility of robotic compared with laparoscopic ISR.
Between January 2008 and May 2011, consecutive patients who underwent robotic or laparoscopic ISR with coloanal anastomosis from seven institutions were included. Propensity score analyses were performed to compare outcomes for groups in a 1 : 1 case-matched cohort. The primary endpoint was 3-year disease-free survival.
A total of 334 patients underwent ISR with coloanal anastomosis, of whom 212 matched patients (106 in each group) formed the cohort for analysis. The overall rate of conversion to open surgery was 0.9 per cent in the robotic ISR group and 1.9 per cent in the laparoscopic ISR group. Nine patients (8.5 per cent) in the laparoscopic group and three (2.8 per cent) in the robotic ISR group still had a stoma at last follow-up (P = 0.075). Total mean hospital costs were significantly higher for robotic ISR (€ 12,757 versus € 9223 for laparoscopic ISR; P = 0.037). Overall 3-year local recurrence rates were similar in the two groups (6.7 per cent for robotic and 5.7 per cent for laparoscopic resection; P = 0.935). The combined 3-year disease-free survival rates were 89.6 (95 per cent c.i. 84.1 to 95.9) and 90.5 (85.4 to 96.6) per cent respectively (P = 0.298).
Robotic ISR with coloanal anastomosis for rectal cancer has reasonable oncological outcomes, but is currently too expensive with no short-term advantages.
机器人经肛门内括约肌间切除术(ISR)与结肠肛管吻合术的肿瘤安全性信息有限。本研究旨在比较机器人与腹腔镜 ISR 的长期可行性。
2008 年 1 月至 2011 年 5 月,来自七个机构的连续接受机器人或腹腔镜 ISR 与结肠肛管吻合术的患者被纳入本研究。通过倾向评分分析,在 1:1 病例匹配队列中比较两组的结果。主要终点是 3 年无病生存率。
共有 334 例患者接受 ISR 与结肠肛管吻合术,其中 212 例匹配患者(每组 106 例)组成分析队列。机器人 ISR 组中转开腹手术的总发生率为 0.9%,腹腔镜 ISR 组为 1.9%。腹腔镜组 9 例(8.5%)和机器人 ISR 组 3 例(2.8%)患者在最后随访时仍有造口(P=0.075)。机器人 ISR 的总平均住院费用明显更高(€12757 对腹腔镜 ISR 的 €9223;P=0.037)。两组患者的总 3 年局部复发率相似(机器人组 6.7%,腹腔镜组 5.7%;P=0.935)。两组患者的 3 年无病生存率分别为 89.6%(95%可信区间 84.1%至 95.9%)和 90.5%(85.4%至 96.6%)(P=0.298)。
机器人经肛门内括约肌间切除术(ISR)与结肠肛管吻合术治疗直肠癌具有合理的肿瘤学结果,但目前费用过高,无短期优势。